Versant Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,602
| Closed | -$38.2K | – | 2408 |
|
|
2024
Q3 | $38.2K | Buy |
4,602
+4,380
| +1,973% | +$36.4K | 0.01% | 552 |
|
|
2024
Q2 | $1.59K | Hold |
222
| – | – | ﹤0.01% | 1564 |
|
|
2024
Q1 | $1.93K | Buy |
222
+153
| +222% | +$1.33K | ﹤0.01% | 1366 |
|
|
2023
Q4 | $452 | Hold |
69
| – | – | ﹤0.01% | 1705 |
|
|
2023
Q3 | $690 | Sell |
69
-17
| -20% | -$170 | ﹤0.01% | 1633 |
|
|
2023
Q2 | $1.07K | Buy |
86
+17
| +25% | +$211 | ﹤0.01% | 1579 |
|
|
2023
Q1 | $957 | Sell |
69
-25
| -27% | -$347 | ﹤0.01% | 1453 |
|
|
2022
Q4 | $1.35K | Buy |
+94
| New | +$1.35K | ﹤0.01% | 1240 |
|
|
2022
Q3 | – | Sell |
-9
| Closed | – | – | 1565 |
|
|
2022
Q2 | $0 | Sell |
9
-7
| -44% | – | ﹤0.01% | 1568 |
|
|
2022
Q1 | $1K | Buy |
+16
| New | +$1K | ﹤0.01% | 1323 |
|